CPC A61K 31/685 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0043 (2013.01); A61K 9/107 (2013.01); A61K 9/127 (2013.01); A61K 31/353 (2013.01); A61K 31/7016 (2013.01); A61K 33/30 (2013.01); A61P 11/08 (2018.01)] | 4 Claims |
1. A pharmacologically active liposomal composition for treating an acute respiratory distress syndrome, the composition comprising phosphatidyl choline, quercetin, lactose, and zinc chloride at a ratio of content of phosphatidyl choline:quercetin:zinc ion in liposomes being from 1:0.027:0.002 to 1:0.027:0.023 wherein the composition is a lyophilized powder having a ratio of components (wt. %) as follows:
quercetin—1,
phosphatidyl choline—36.7,
zinc ion—0.11-0.43,
lactose—54.51,
remainder—water, chloride ion.
|